The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
| | |
PRELIMINARY PROSPECTUS | | SUBJECT TO COMPLETION, DATED SEPTEMBER 23, 2021 |
$40,000,000
Hash Space Acquisition Corp
4,000,000 Units
Hash Space Acquisition Corp is a newly incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us.
This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one of our ordinary shares and one right. Each right entitles the holder thereof to receive one-tenth (1/10) of one ordinary share upon the consummation of an initial business combination, as described in more detail in this prospectus. We will have 12 months from the closing of this offering to consummate an initial business combination, unless otherwise extended as described herein. If we anticipate that we may not be able to consummate our initial business combination within 12 months, our insiders or their affiliates may, but are not obligated to, extend the period of time to consummate a business combination two times by an additional three months each time (for a total of up to 18 months to complete a business combination), as described in more detail in this prospectus. We may also seek to amend our charter or governing instruments to extend the time to consummate an initial business combination in order to effectuate our initial business combination. If we are unable to consummate our initial business combination within such period, we will redeem 100% of the public shares for cash, subject to applicable law and certain conditions as further described herein.
We have also granted the underwriters a 45-day option to purchase up to an additional 600,000 units to cover over-allotments, if any.
We will provide our public shareholders with the opportunity to redeem all or a portion of their ordinary shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account described below as of two business days prior to the consummation of our initial business combination, including interest (which interest shall be net of taxes payable) divided by the number of then issued and outstanding ordinary shares that were sold as part of the units in this offering, which we refer to collectively as our public shares, subject to the limitations described herein. If we are unable to complete our initial business combination within 12 months from the closing of this offering (or up to 18 months from the closing of this offering if we extend the period of time to consummate a business combination by the maximum amount), we will redeem 100% of the public shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less up to $50,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable) divided by the number of then issued and outstanding public shares, subject to applicable law and as further described herein.
Our sponsor, Fucheng Technology Group Limited, a Hong Kong limited liability company, has committed to purchase an aggregate of 270,000 units (or 291,000 units if the over-allotment option is exercised in full) at a price of $10.00 per unit ($2,700,000 in the aggregate, or $2,910,000 if the over-allotment option is exercised in full). Each placement unit will be identical to the units sold in this offering, except as described in this prospectus. The placement units will be sold in a private placement that will close simultaneously with the closing of this offering.
A limited number of anchor investors which are not affiliated with any member of our management have each expressed to us an interest in purchasing up to 2,500,000 units in this offering at the offering price of $10.00, and such allocations will be determined by the underwriters. There can be no assurance that the anchor investors will acquire any units in this offering, or as to the amount of such units the anchor investors will retain, if any, prior to or upon the consummation of our initial business combination. Other than the units sold in this offering, the anchor investors will not receive any additional consideration for purchasing any units in this offering. The anchor investors will also agree to hold their 1,950,000 ordinary shares through the consummation of our initial business combination and not seek redemption of such shares in connection therewith. For a discussion of certain additional arrangements with the anchor investors, see “Summary — The Offering — Expression of Interest.” The underwriters will receive upfront underwriting commission of $0.17 per unit and deferred underwriting discounts or commissions of $0.30 per unit on the units which may be purchased by the anchor investors, as set forth in “Underwriting” below.
Our initial shareholders currently own 1,150,000 ordinary shares, up to 150,000 of which will be surrendered to us for no consideration after the closing of this offering depending on the extent to which the underwriters’ over-allotment option is exercised, which (unless otherwise provided in our initial business combination agreement).
Prior to this offering, there has been no public market for our units, ordinary shares or rights. We have applied to list our units on The Nasdaq Capital Market, or Nasdaq, under the symbol “HACUU” on or promptly after the date of this prospectus. We cannot guarantee that our securities will be approved for listing on Nasdaq. We expect that the ordinary shares and rights comprising the units to begin separate trading on the 90th day following the date of this prospectus unless Chardan Capital Markets, which we refer to as “Chardan” informs us of their decision to allow earlier separate trading, subject to our satisfaction of certain conditions. Once the securities comprising the units begin separate trading, we expect that the ordinary shares and rights will be listed on the Nasdaq under the symbols HAC” and “HACUR,” respectively.
As a blank check company with no material operations of our own, we conduct our operations through an office space in Hong Kong and our sponsor and all of our executive officers and directors are located in or have significant ties to the People’s Republic of China, or PRC. Although we will not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau), we may be subject to the certain legal and operational risks. Any of these risks could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless. For a detailed description of such risks, see “Risks Relating to Being Located in China.”
We are an “emerging growth company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. Investing in our securities involves risks. See “Risk Factors” on page 33. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.
| | | | | | | | | | | | |
| | Price to Public | | | Underwriting Discounts and Commissions(1)(2) | | | Proceeds, before expenses, to us | |
Per Unit | | $ | 10.00 | | | $ | 0.55 | | | $ | 9.45 | |
| | | | | | | | | | | | |
Total | | $ | 40,000,000 | | | $ | 2,200,000 | | | $ | 37,800,000 | |
| | | | | | | | | | | | |
(1) | Includes $0.30 per unit, or $1,200,000 (or $1,380,000 if the over-allotment option is exercised in full) in the aggregate payable to the underwriters for deferred underwriting commissions to be placed in a trust account located in the United States as described herein. The deferred commissions will be released to the underwriters only on completion of an initial business combination, as described in this prospectus. Does not include certain fees and expenses payable to the underwriters in connection with this offering. See also “Underwriting” for a description of compensation and other items of value payable to the underwriters. |
(2) | Assumes investors sourced by the sponsor do not purchase any units in this offering, for which Chardan will be entitled to receive an aggregate underwriting discounts of $0.47 per unit. See “Underwriting” for additional information. |
Of the proceeds we receive from this offering and the sale of the private placement units described in this prospectus, $40,400,000 ($10.10 per unit), or $46,460,000 ($10.10 per unit) if the underwriters’ over-allotment option is exercised in full, will be deposited into a trust account located in the United States with Continental Stock Transfer & Trust Company acting as trustee. The proceeds deposited in the trust account could become subject to the claims of our creditors, if any, which could have priority over the claims of our public shareholders.
The underwriters are offering the units for sale on a firm commitment basis. Delivery of the units will be made on or about , 2021.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
No invitation, whether directly or indirectly, may be made to the public in the Cayman Islands to subscribe for our securities.
Book-Running Manager
Chardan
The date of this prospectus is , 2021